Fat Injection for Rectocele Treatment: A Novel Approach

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-60
SponsorCairo University

About this trial

This clinical trial aims to evaluate the effectiveness of autologous fat grafting as a novel treatment for rectocele, a condition characterized by the herniation of rectal tissue into the posterior vaginal wall. Women aged 18 to 60 years with mild to moderate rectocele, presenting with symptoms such as obstructive defecation or vaginal bulge, will undergo submucosal fat injections. The study will assess the procedure\'s ability to alleviate symptoms and reduce prolapse recurrence. This prospective, single-arm trial will be conducted at Cairo University Hospitals.

Eligibility criteria

Qualifiers

Female patients aged between 18 and 60 years.

Diagnosis of rectocele confirmed by defecography, with a rectocele size of 2 cm (mild) to 4 cm (moderate).

Presenting with symptoms of obstructive defecation syndrome, including constipation, incomplete defecation, and/or vaginal bulge.

Able to provide written informed consent to participate in the study.

Disqualifiers

Patients who have previously undergone surgical repair of rectocele.

Presence of thrombosed hemorrhoids.

History of sclerotherapy injection for rectocele.

Diagnosis of anal stenosis.

Trial design

Treatments tested in this trial

  • Autologous Fat Injection for Rectocele

Treatment groups

25 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators